Liberate Bio Integrates Quantum-Sis Next-Generation Protein Sequencing Platform to Enhance Gene Therapy Development - StockTitan
| QSIAW Stock | USD 1.41 0.17 13.71% |
Slightly above 53% of Quantum Si's sophisticated investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Quantum Si incorporated suggests that some traders are interested. Quantum Si's investing sentiment can be driven by a variety of factors including economic data, Quantum Si's earnings reports, geopolitical events, and overall market trends.
Quantum |
Liberate Bio Integrates Quantum-Sis Next-Generation Protein Sequencing Platform to Enhance Gene Therapy Development StockTitan
Read at news.google.com
 |
Quantum Si Fundamental Analysis
We analyze Quantum Si's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Quantum Si using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Quantum Si based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Quantum Si is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Quantum Si incorporated Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Quantum Si stock to make a market-neutral strategy. Peer analysis of Quantum Si could also be used in its relative valuation, which is a method of valuing Quantum Si by comparing valuation metrics with similar companies.
Peers
Quantum Si Related Equities
| HCWB | HCW Biologics | 4.65 | ||||
| NTLA | Intellia Therapeutics | 2.19 | ||||
| VERV | Verve Therapeutics | 1.81 | ||||
| SEER | Seer | 1.76 | ||||
| NRIX | Nurix Therapeutics | 1.07 | ||||
| MNOV | MediciNova | 0.47 | ||||
| BEAM | Beam Therapeutics | 1.86 | ||||
| PRME | Prime Medicine, | 4.14 | ||||
| PASG | Passage Bio | 14.93 |
Additional Tools for Quantum Stock Analysis
When running Quantum Si's price analysis, check to measure Quantum Si's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quantum Si is operating at the current time. Most of Quantum Si's value examination focuses on studying past and present price action to predict the probability of Quantum Si's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quantum Si's price. Additionally, you may evaluate how the addition of Quantum Si to your portfolios can decrease your overall portfolio volatility.